Share Email Print
cover

Proceedings Paper

Vessel constriction correlated with local singlet oxygen generation during vascular targeted photodynamic therapy
Author(s): Lisheng Lin; Yirong Li; Jinde Zhang; Zou Tan; Defu Chen; Shusen Xie; Ying Gu; Buhong Li
Format Member Price Non-Member Price
PDF $14.40 $18.00

Paper Abstract

In this study, the vessel constriction was measured as a biological indicator of acute vascular response after vascular targeted photodynamic therapy (V-PDT). During V-PDT treatment, the near-infrared (NIR) singlet oxygen (1O2) luminescence at 1270 nm generated in blood vessels in a dorsal skinfold window chamber model in vivo was directly monitored using a custom built high-sensitive NIR imaging system. In order to compare the acute vascular response, various irradiances with the same light dose were utilized for treatments. The obtained results show that the complete arteriole constriction occurred frequently, while some of the larger veins were constricted partially. For the vessels that have significant constriction after V-PDT, our preliminary data suggest that the vasoconstriction in the selected ROIs are roughly correlated with the local cumulative 1O2 luminescence intensities. This study implies that the 1O2 luminescence dosimetry maybe also effective for evaluating V-PDT efficiency.

Paper Details

Date Published: 18 November 2014
PDF: 6 pages
Proc. SPIE 9268, Optics in Health Care and Biomedical Optics VI, 92680T (18 November 2014); doi: 10.1117/12.2074038
Show Author Affiliations
Lisheng Lin, Fujian Normal Univ. (China)
Yirong Li, Fujian Normal Univ (China)
Jinde Zhang, Fujian Normal Univ. (China)
Zou Tan, Fujian Normal Univ. (China)
Defu Chen, Fujian Normal Univ. (China)
Chinese PLA General Hospital (China)
Shusen Xie, Fujian Normal Univ (China)
Ying Gu, Chinese PLA General Hospital (China)
Buhong Li, Fujian Normal Univ. (China)


Published in SPIE Proceedings Vol. 9268:
Optics in Health Care and Biomedical Optics VI
Qingming Luo; Xingde Li; Ying Gu; Yuguo Tang, Editor(s)

© SPIE. Terms of Use
Back to Top